FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39390511000001103: Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Mar 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
609171000001110 Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
609181000001112 Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Is a Misoprostol 25microgram tablets true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Is a Angusta true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Has specific active ingredient Misoprostol true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) 8 tablet Has AMP True Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start